Macrogenics (MGNX) Tops Q3 EPS by 69c, Beats on Revenue

Macrogenics (NASDAQ: MGNX) reported Q3 EPS of $0.90, $0.69 better than the analyst estimate of $0.21. Revenue for the quarter came in at $110.71 million versus the consensus estimate of $87.61 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.

You May Also Be Interested In

• HSBC Downgrades China Power International (2380:HK) (CPWIF) to Hold
• OBOOK Holdings posts $18.8M net loss as OwlPay Harbor volume rises
• HSBC Downgrades Kakao Corp. (035720:KS) to Hold